Tafinlar (dabrafenib) - Novartis
Keytruda (pembrolizumab) - Merck (MSD)
Mekinist (trametinib) - Novartis, BeOne Medicines
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer (clinicaltrials.gov) - Oct 21, 2026 - P2 | N=12 | Not yet recruiting | Sponsor: Washington University School of Medicine 
New P2 trial • Oncology • Solid Tumor • Thyroid Gland Anaplastic Carcinoma • Thyroid Gland Carcinoma
http://clinicaltrials.gov/ct2/show/NCT07886905
 
Oct 21, 2026
 
Prev Next